Supriya Lifescience Limited (SUPRIYA.NS)
INR 698.8
(3.55%)
INR 698.8
(3.55%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 14.80 INR | 32.62% |
| 2022 | 11.16 INR | -40.83% |
| 2021 | 18.86 INR | 11.66% |
| 2020 | 16.89 INR | 68.39% |
| 2019 | 10.03 INR | -35.0% |
| 2018 | 15.43 INR | 1196.64% |
| 2017 | 1.19 INR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 5.71 INR | 2.88% |
| 2024 Q1 | 5.55 INR | 20.92% |
| 2023 Q1 | 3.54 INR | -25.47% |
| 2023 Q4 | 4.59 INR | 24.05% |
| 2023 Q3 | 3.70 INR | 24.58% |
| 2023 Q2 | 2.97 INR | -16.1% |
| 2023 FY | - INR | 32.62% |
| 2022 Q4 | 4.75 INR | 302.54% |
| 2022 Q3 | 1.18 INR | -43.81% |
| 2022 Q2 | 2.10 INR | -33.12% |
| 2022 Q1 | 3.14 INR | -45.3% |
| 2022 FY | - INR | -40.83% |
| 2021 Q2 | 22.79 INR | 652.15% |
| 2021 FY | - INR | 11.66% |
| 2021 Q1 | 3.03 INR | -84.12% |
| 2021 Q4 | 5.74 INR | 16.43% |
| 2021 Q3 | 4.93 INR | -78.37% |
| 2020 Q3 | 6.14 INR | 0.0% |
| 2020 FY | - INR | 68.39% |
| 2020 Q4 | 19.08 INR | 210.75% |
| 2019 FY | - INR | -35.0% |
| 2018 FY | - INR | 1196.64% |
| 2017 FY | - INR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Biocon Limited | 8.55 INR | -73.099% |
| Blue Jet Healthcare Limited | 9.44 INR | -56.78% |
| Concord Biotech Limited | 29.45 INR | 49.745% |
| Dishman Carbogen Amcis Limited | -9.79 INR | 251.175% |
| Jubilant Ingrevia Limited | 11.56 INR | -28.028% |
| Lyka Labs Limited | -0.75 INR | 2073.333% |
| Panacea Biotec Limited | -0.19 INR | 7889.474% |
| Piramal Pharma Limited | 0.14 INR | -10471.429% |
| SMS Lifesciences India Limited | 30.08 INR | 50.798% |
| Syngene International Limited | 12.71 INR | -16.444% |
| TAKE Solutions Limited | -8.18 INR | 280.929% |
| Zota Health Care Limited | -5.55 INR | 366.667% |